Clinical Ligand Assay Society's Company Profile

10:26 EST 19th December 2018 | BioPortfolio

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and fostering communication and cooperation among individuals in laboratories, in medicine, in academia and industry. Clinical Ligand Assay Society Goals
Ligand Assay Technology
To maintain an organization focused on the diagnostic, therapeutic, analytical and investigative use of ligand tehcnology assays and related methods.
To expand ligand assay technology by promoting education, encouraging basic and clinical research and advancing the practice of ligand assay as applied to biochemical, medical, pharmaceutical, veterinary, agricultural, environmental and industrial sciences.
To sponsor a national meeting, scientific symposia, review course, certification programs, workshops and publications which increase the understanding of ligand assay technology development and application.
To promote cooperation and mutual consultation among members working in laboratories, clinics, hospitals, educational institutions and industry.

Chapter Goals of
Clinical Ligand Assay Society New England

To provide the best educational events in the ligand field.
To provide several networking opportunities during the year.
To work directly with other societies and organizations in planning educational events. Northeast Region Conference is our pre-eminent meeting


Phone: 508-856-6003
Fax: 508-856-1095

News Articles [1410 Associated News Articles listed on BioPortfolio]

New Troponin Assay May Facilitate Faster Rule-Out of AMI

In a preliminary study, a novel troponin assay with a 15-minute turnaround time shows similar accuracy and clinical sensitivity to a high-sensitivity assay. Medscape Medical News

Ligand Pharma Makes Offer To Buy Vernalis For About $43 Mln In Cash

LONDON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND)and Vernalis plc (VER.L) announce that Ligand has declared its firm intention to acquire the entire issued and to be issued shares of Vernalis ...

Homogeneous BTK occupancy assay

(SLAS (Society for Laboratory Automation and Screening)) A time-resolved fluorescence resonance energy transfer-based BTK occupancy assay measures target engagement in peripheral blood mononuclear cel...

Ligand Partners with iMetabolic Biopharma

The agreement will allow iMetabolic to fully access Ligand’s OmniAb therapeutic antibody platform, which includes OmniRat, OmniMouse, OmniFlic and OmniChicken. The post Ligand Partners with iMetabol...

Ligand to buy UK biotech Vernaliss for $43 million

San Diego-based Ligand would acquire programmes in respiratory, oncology and CNS

M&As this week: Ligand Pharmaceuticals, CVS Health, Mundipharma

Ligand Pharmaceuticals has acquired Vernalis for $42.3m giving the former access to a portfolio of eight fully funded programmes, as...Read More... The post M&As this week: Ligand Pharmaceuticals...

Luminex starts clinical trials for VERIGENE II gastrointestinal assay

Luminex has started clinical studies for the gastrointestinal (GI) assay on the VERIGENE II system.

With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence

Ligand Pharmaceuticals said Wednesday that its acquisition of U.K.-based biotech Vernalis has closed. The $42.3 million deal netted the San Diego company eight partner programs and a 70-person R&D...

PubMed Articles [5704 Associated PubMed Articles listed on BioPortfolio]

Analytical Validation and Clinical Utility of an Immunohistochemical Programmed Death Ligand-1 Diagnostic Assay and Combined Tumor and Immune Cell Scoring Algorithm for Durvalumab in Urothelial Carcinoma.

Clinical responses to anti-programmed death receptor-1 and anti-programmed death ligand-1 (PD-L1) agents are generally improved in patients with high PD-L1 expression compared with those with low/nega...

Implementation of fluorescence anisotropy-based assay for the characterization of ligand binding to dopamine D receptors.

Dopamine receptors, which belong to the family of G protein-coupled receptors, are very substantial regulators in the brain and therefore important targets in drug discovery. Radioligand binding assay...

Inconsistent detection of an evolving HIV-1 infection by a popular high-throughput screening assay.

Dependence receptors: the dark side awakens.

Transmembrane receptors are usually seen as on and off switch: when the specific ligand is bound, the receptor is on and transduces a downstream signal, while when the ligand is absent, the receptor i...

The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.

Clinical Trials [3052 Associated Clinical Trials listed on BioPortfolio]

Clinical Performance Evaluation of DxN CMV Assay

The DxN Cytomegalovirus (CMV) assay is an in vitro diagnostic assay intended as an aid in the management of CMV-infected individuals undergoing antiviral therapy. the purpose of the study ...

Clinical Performance Evaluation of AMH Assay

The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay i...

Clinical Evaluation of the QuantiFERON CMV Assay

Validate the use of the device in the clinical setting for assessing the risk of CMV Infection in SOT recipients after the completion of antiviral prophylaxis.

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...

Clinical Evaluation of the PROGENSA(R) PCA3 Assay in Men With a Previous Negative Biopsy Result

The objective of this multi-center clinical study is to determine the association of the PCA3 Score with prostate biopsy outcome and validate the assay's performance characteristics in men...

Companies [2339 Associated Companies listed on BioPortfolio]

Clinical Ligand Assay Society's

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and f...

Clinical Ligand Assay Society

MISSION The Clinical Ligand Assay Society mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitione...

BioAnalab Ltd

BioAnaLab is a leading CRO specialising in analysis of biological therapeutics. We use ligand binding and cell based assays for toxicokinetic/pharmacokinetic and pharmacodynamic analysis, immunopheno...

Ligand Pharmaceuticals

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and d...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, in...

More Information about "Clinical Ligand Assay Society's" on BioPortfolio

We have published hundreds of Clinical Ligand Assay Society's news stories on BioPortfolio along with dozens of Clinical Ligand Assay Society's Clinical Trials and PubMed Articles about Clinical Ligand Assay Society's for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clinical Ligand Assay Society's Companies in our database. You can also find out about relevant Clinical Ligand Assay Society's Drugs and Medications on this site too.

Quick Search


Relevant Topic

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Corporate Database Quicklinks

Searches Linking to this Company Record